State of New Jersey Common Pension Fund D Boosts Stock Position in Enovis Co. (NYSE:ENOV)

State of New Jersey Common Pension Fund D boosted its position in shares of Enovis Co. (NYSE:ENOV) by 6.8% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 46,370 shares of the company’s stock after acquiring an additional 2,966 shares during the quarter. State of New Jersey Common Pension Fund D owned 0.08% of Enovis worth $2,035,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently bought and sold shares of the business. Pinnacle Bancorp Inc. increased its stake in Enovis by 54.5% during the 4th quarter. Pinnacle Bancorp Inc. now owns 850 shares of the company’s stock worth $37,000 after buying an additional 300 shares during the period. Aigen Investment Management LP raised its stake in shares of Enovis by 5.1% in the third quarter. Aigen Investment Management LP now owns 8,859 shares of the company’s stock valued at $381,000 after acquiring an additional 430 shares in the last quarter. UMB Bank n.a. boosted its holdings in Enovis by 128.2% in the fourth quarter. UMB Bank n.a. now owns 778 shares of the company’s stock valued at $34,000 after purchasing an additional 437 shares during the period. New York State Teachers Retirement System grew its stake in Enovis by 3.5% during the 4th quarter. New York State Teachers Retirement System now owns 13,538 shares of the company’s stock worth $594,000 after purchasing an additional 457 shares in the last quarter. Finally, FMR LLC increased its holdings in Enovis by 20.5% during the 3rd quarter. FMR LLC now owns 2,840 shares of the company’s stock worth $122,000 after purchasing an additional 484 shares during the period. 98.45% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Separately, Needham & Company LLC restated a “buy” rating and set a $65.00 target price on shares of Enovis in a research note on Thursday, November 7th.

Enovis Trading Down 2.6 %

ENOV opened at $42.77 on Monday. The business’s 50-day simple moving average is $45.08 and its 200-day simple moving average is $44.38. The company has a market cap of $2.43 billion, a P/E ratio of -19.53 and a beta of 1.94. Enovis Co. has a one year low of $38.27 and a one year high of $65.03. The company has a debt-to-equity ratio of 0.40, a quick ratio of 1.12 and a current ratio of 2.27.

About Enovis

Enovis Corporation operates as a medical technology company focus on developing clinically differentiated solutions worldwide. It also manufactures and distributes medical devices which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company operates through Prevention and Recovery, and Reconstructive segments.